Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Details for Australian Patent Application No. 2005212257 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Cottrell, Kevin M.; Court, John J.; Farmer, Luc J.; Deininger, David D.; Pitlik, Janos

Agent Cullen & Co

Pub. Number AU-A-2005212257

PCT Pub. Number WO2005/077969

Priority 60/541,738 04.02.04 US

Filing date 4 February 2005

Wipo publication date 25 August 2005

International Classifications

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 7/02 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/18 (2006.01) Peptides having more than 20 amino acids

Event Publications

24 August 2006 PCT application entered the National Phase

  PCT publication WO2005/077969 Priority application(s): WO2005/077969

7 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005212258-Methods for making 3-O-protected morphinones and 3-O-protected morphinone dienol carboxylates

2005212242-Datum based interchangeable fuel cell cartridges